UC San Diego researchers report successfully removing the nucleus from a type of ubiquitous cell, then using the genetically engineered cell as a unique cargo-carrier to deliver therapeutics precisely to diseased tissues.Researchers at University of California San Diego School of Medicine and Moores
Related Articles

News
Jacobs Medical Center Marks Fifth Anniversary, Achievements and Milestones
October 12, 2021
sandiegobiotech
News, UCSD News
Comments Off on Jacobs Medical Center Marks Fifth Anniversary, Achievements and Milestones
Jacobs Medical Center at UC San Diego Health marks its fifth anniversary and celebrates achievements and milestones while providing the most advanced medical and surgical care in the region.
[…]

News
With Landmark Gift, UC San Diego Will Map Compassion in the Brain, then Prove its Power
July 22, 2019
sandiegobiotech
News
Comments Off on With Landmark Gift, UC San Diego Will Map Compassion in the Brain, then Prove its Power

News
UC San Diego Partners with 5 Leading Diagnostics Manufacturers to Boost COVID-19 Testing
March 20, 2020
sandiegobiotech
News, UCSD News
Comments Off on UC San Diego Partners with 5 Leading Diagnostics Manufacturers to Boost COVID-19 Testing
Partnering with five diagnostics manufacturers, UC San Diego is significantly ramping up testing for COVID-19, projecting capacity to complete up to 1,500 tests daily within two to three weeks.
[…]